The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Menopause

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.gme.0000198485.70703.7aPMID 16837886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.

  2005cited by this paper
• Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.

  2005cited by this paper
• Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.

  2003influential reference
• Metabolic, inflammatory and haemostatic effects of a low‐dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?

  2003influential reference
• Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue

  2003influential reference
• A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Effect of Medroxyprogesterone Acetate on Vascular Inflammatory Markers in Postmenopausal Women Receiving Estrogen

  2002cited by this paper
• Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women

  2001cited by this paper
• Different Effects of Oral and Transdermal Hormone Replacement Therapies on Factor IX, APC Resistance, t-PA, PAI and C-reactive Protein

  2001cited by this paper
• The Effects of Hormone Replacement Therapy (HRT) on Hemostatic Variables in Women with Previous Venous Thromboembolism – Results from a Randomized, Double-Blind, Clinical Trial

  2001cited by this paper
• A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease

  2000cited by this paper
• Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.

  2000cited by this paper
• Impaired Procoagulant-anticoagulant Balance during Hormone Replacement Therapy?

  2000cited by this paper
• Hormone replacement therapy and increased plasma concentration of C-reactive protein.

  1999cited by this paper
• Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

  1999cited by this paper
• Elevated C-reactive protein levels in overweight and obese adults.

  1999cited by this paper
• Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.

  1999cited by this paper
• Increased C-reactive Protein Levels during Short-term Hormone Replacement Therapy in Healthy Postmenopausal Women

  1999cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• IL-6 expression by oral fibroblasts is regulated by androgen.

  1998cited by this paper
• Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

  1998cited by this paper
• Effects of estrogen replacement therapy on thrombin generation.

  1997cited by this paper
• Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.

  1997cited by this paper
• Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.

  1997cited by this paper
• Effects on Haemostasis of Hormone Replacement Therapy with Transdermal Estradiol and Oral Sequential Medroxyprogesterone Acetate: A 1 -year, Double-blind, Placebo-controlled Study

  1996cited by this paper
• Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.

  1996cited by this paper
• Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

  1996cited by this paper
• Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

  1996cited by this paper
• Fibrin D-dimer: a useful clinical marker of thrombogenesis?

  1995cited by this paper
• Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma: Its Role in Thrombotic Disease

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• The Effects of Transdermal Estradiol and Oral Conjugated Estrogens on Haemostasis Variables

  1994cited by this paper
• Coagulation Activation Following Estrogen Administration to Postmenopausal Women

  1992cited by this paper
• Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women.

  1991cited by this paper
• Haemostatic changes during continuous oestradiolprogestogen treatment of postmenopausal women

  1990cited by this paper
• Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration.

  1988cited by this paper
• Biologic effects of transdermal estradiol

  1986cited by this paper
• Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.

  1985cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Multi-omic biomarkers in premature ovarian insufficiency.

  2025cites this paper
• Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study

  2023cites this paper
• Plasma fibrinogen levels and all-cause and cause-specific mortality in an Italian adult population: results from the Moli-sani study

  2023cites this paper
• The effect of 17β-estradiol plus norethisterone acetate on blood pressure and inflammation markers: A meta-analysis of randomized controlled trials.

  2023cites this paper
• The effect of transdermal 17β-estradiol combined with norethisterone acetate treatment on the lipid profile in postmenopausal women: a meta-analysis and systematic review of randomized controlled trials.

  2022cites this paper
• The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis

  2022cites this paper
• Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden

  2022cites this paper
• The effect of 17β-estradiol plus norethisterone acetate treatment on lipoprotein (a), atherogenic and anti-atherogenic apolipoproteins levels in postmenopausal women: A meta-analysis of randomized controlled trials.

  2022cites this paper
• Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology

  2021cites this paper
• Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling

  2020cites this paper
• Climacteric Status at the Age of 46: Impact on Metabolic Outcomes in Population-Based Study.

  2019cites this paper
• Identification of serum biomarkers for premature ovarian failure.

  2019cites this paper
• Transdermal estradiol for the management of refractory uremic bleeding.

  2018cites this paper
• Impact of meal fatty acid composition on postprandial lipaemia, vascular function and blood pressure in postmenopausal women

  2018cites this paper
• Sex differences in lipid and lipoprotein metabolism

  2018influential citation
• Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study

  2018cites this paper
• Variations of Sex Hormones across the Menstrual Cycle: Correlations to Depressive Symptoms, Hostility, Lipidemic and Haemostatic Factors

  2018cites this paper
• Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data

  2017cites this paper
• Role of Estrogens in the Regulation of Liver Lipid Metabolism.

  2017influential citation
• Norethindrone Acetate: Pharmacokinetics, Potency and Alternative Clinical Applications

  2017cites this paper
• Usporedba transdermalne i oralne primjene hormonskog nadomjesnog liječenja kod žena u postmenopauzi

  2017cites this paper
• The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.

  2017cites this paper
• The effects of progesterones on blood lipids in hormone replacement therapy

  2017cites this paper
• Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.

  2016cites this paper
• Sex differences in the metabolic dysfunction and insulin resistance of skeletal muscle glucose transport following high fructose ingestion.

  2016cites this paper
• Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review

  2016cites this paper
• Hormone therapy in menopause: An update on cardiovascular disease considerations.

  2015cites this paper
• Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study

  2015cites this paper
• Female-Specific Factors for IHD: Across the Reproductive Lifespan

  2015cites this paper
• Hormone therapy and hemostasis among postmenopausal women: a review

  2014cites this paper
• Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study

  2014cites this paper
• Is transdermal menopausal hormone therapy (MHT) associated with an increased cardiovascular risk?

  2014cites this paper
• Ischaemic heart disease in the ageing woman.

  2013cites this paper
• Oral Contraceptive Use and the ECG: Evidence of an Adverse QT Effect on Corrected QT Interval

  2013cites this paper
• Management of Estrogen Deficiency

  2013cites this paper
• Inflammation Through a Psychoneuroimmunological Lens

  2013cites this paper
• Best Practice & Research Clinical Obstetrics and Gynaecology

  2013cites this paper
• Estudio de las características metabólicas, hormonales e inmunoinflamatorias de mujeres con síndrome de ovarios poliquísticos con o sin obesidad. Análisis del impacto del tratamiento con atorvastatina

  2013cites this paper
• Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women

  2012influential citation
• Effects of diabetes and ovariectomy on rat hippocampus (A biochemical and stereological study)

  2012cites this paper
• Understanding the biological mechanisms underlying acquired risk factors for venous thrombosis : studies in mice

  2012cites this paper
• Contraception in patients with heart failure.

  2012cites this paper
• [Benefit of vanadium compound in therapy for cardiovascular diseases].

  2012cites this paper
• ESTUDIO DE LAS CARACTERÍSTICAS METABÓLICAS, HORMONALES E INMUNOINFLAMATORIAS DE MUJERES CON SÍNDROME DE OVARIOS POLIQUÍSTICOS CON O SIN OBESIDAD. ANÁLISIS DEL IMPACTO DEL TRATAMIENTO CON ATORVASTATINA

  2012cites this paper
• for : studies in

  2012cites this paper
• Contraception in Patients With Heart Failure C LINICIAN U PDATE

  2012cites this paper
• Transdermal estradiol gel for the treatment of symptomatic postmenopausal women

  2012cites this paper
• Metabolic and hormonal parameters in post-menopausal women 10 years after transdermal oestradiol treatment, alone or combined to micronised oral progesterone

  2011cites this paper
• Crosstalk between the sympathetic nervous system, inflammation and coagulation in gestational diabetes; a therapeutic approach in postmenopausal hypertension

  2011cites this paper
• Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-&agr; genotypes

  2011cites this paper
• Hormone replacement therapy in the geriatric patient: current state of the evidence and questions for the future. Estrogen, progesterone, testosterone, and thyroid hormone augmentation in geriatric clinical practice: part 1.

  2011cites this paper
• The effects of hormone therapy on metabolic risk factors in postmenopausal Korean women

  2011cites this paper
• Changes in hemostatic parameters after oral and transdermal hormone therapy in postmenopausal women

  2011cites this paper
• Hormonal Contraception and Hormone Replacement Therapy in People with Headache

  2011cites this paper
• Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study.

  2011cites this paper
• No effect of Implanon® on inflammatory cardiovascular parameters

  2011cites this paper
• 49 Hormonal Contraception and Hormone Replacement Therapy in People with

  2011cites this paper
• Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women

  2010cites this paper
• Effects of different doses of physical activity on C-reactive protein among women.

  2010cites this paper
• A importância da via de administração na terapia hormonal do climatério

  2010cites this paper
• Transdermal hormone therapy of the menopausal period – state of the art in 2010

  2010cites this paper
• A Review of Transdermal Nonpatch Estrogen Therapy for the Management of Menopausal Symptoms

  2010cites this paper
• Posición oficial de la Sociedad Chilena de Climaterio para el manejo clínico de la mujer climatérica

  2010cites this paper
• [Official position of the Chilean Society of Climacteric on the management of climacteric women].

  2010cites this paper
• Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status

  2010cites this paper
• To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

  2009cites this paper
• Effect of hormone replacement therapy on inflammatory biomarkers.

  2009cites this paper
• biphasic effects of hormone treatment on risk of cardiovascular disease rESolVINg THE PArAdox IN PoSTmENoPAUSAl womEN

  2009cites this paper
• Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate.

  2009cites this paper
• Relationships between vascular resistance and energy deficiency, nutritional status and oxidative stress in oestrogen deficient physically active women

  2009cites this paper
• Vascular Effects of Estrogen and Progestins and Risk of Coronary Artery Disease: Importance of Timing of Estrogen Treatment

  2009cites this paper
• Perfil lipídico en pacientes menopáusicas tratadas con estradiol-acetato de noretisterona oral o estradiol transdérmico

  2009cites this paper
• Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy

  2009cites this paper
• Effects of hormonal treatment on lipids in patients with cancer.

  2009cites this paper
• Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.

  2009cites this paper
• Short-term ethinylestradiol treatment suppresses inferior caval vein thrombosis in obese mice

  2009cites this paper
• biphasiceffectsof hormonetreatmentonrisk ofcardiovasculardisease

  2009cites this paper
• Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.

  2009cites this paper
• Estrogen replacement and migraine.

  2009cites this paper
• Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement.

  2009cites this paper
• On a Minimal Mathematical Model for Regulation of Factor Va by Activated Protein C

  2008cites this paper
• Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.

  2008cites this paper
• Is there a place for postmenopausal hormone therapy use in women with lupus?

  2008cites this paper
• The effect of different preparations of hormone therapy on tumor necrosis factor-α levels in women with surgical menopause

  2008cites this paper
• HORMONE REPLACEMENT THERAPY AND VENOUS THROMBOEMBOLISM

  2008cites this paper
• Hormonal therapy and thromboembolic disease

  2008cites this paper
• Hormones in wellness and disease prevention: common practices, current state of the evidence, and questions for the future.

  2008cites this paper
• Review Article: A New Approach to Menopausal Therapy: The Tissue Selective Estrogen Complex

  2008cites this paper
• Sleep and Menopause Hormone Therapy and Sleep Deprivation

  2008cites this paper
• Hormone therapy and risk of myocardial infarction: a national register study.

  2008cites this paper
• Hormones inWellnessand Disease Prevention : Common Practices , Current State of theEvidence , and Questionsfor the Future

  2008cites this paper
• Can menopausal hormone therapy prevent coronary heart disease?

  2008cites this paper
• Efeitos do estradiol 17beta oral baixa dose e drospirenona ou não oral associado à progesterona sobre variáveis relacionadas com função endotelial, inflamação e perfil metabólico em pacientes pós-menopausa recente

  2007cites this paper
• Effects of hormone treatment on hemostasis variables

  2007cites this paper
• Combined Continuous Ethinyl Estradiol/Norethindrone Acetate Does Not Improve Forearm Blood Flow in Postmenopausal Women at Risk for Cardiovascular Events: A Pilot Study

  2007cites this paper
• Systemic lupus erythematosus and hormone replacement therapy

  2007cites this paper
• Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?

  2007cites this paper
• Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.

  2007cites this paper
• Anti-inflammatory and immunomodulatory strategies to protect the perinatal brain.

  2007cites this paper
• SEGUNDO CONSENSO ARGENTINO SOBRE PATOLOGÍAS ENDOCRINOLÓGICAS

  2007cites this paper